Answers are grounded in this paper and cite their sources.
A single dose of lunsekimig was well tolerated, significantly suppressed T2 inflammation and improved lung function in mild-to-moderate asthma.
No takes yet. Share an insight, caveat, or question.
Deiteren et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: